Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the lagos university teaching hospital

HIV/AIDS - Research and Palliative Care

Volumn 3, Issue , 2011, Pages 101-105

  Osunkalu, Vincent O ^a   Akanmu, Sulaimon A ^a   Ofomah, Nkolika J ^a   Onyiaorah, Igwebuike V ^b   Adediran, Adewumi A ^a   Akinde, Ralph O ^a   Onwuezobe, Ifeanyi A ^c  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^c UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Neurological complication; Seroprevalence; Toxoplasma gondii antibody (Toxo IgG)

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGICAL COMPLICATION; NIGERIA; SEROPREVALENCE; TOXOPLASMA GONDII;

EID: 85014504400     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: 10.2147/HIV.S15532     Document Type: Article

References (18)

1. Wilson M, McAuley JB. Toxoplasma Manual of Clinical Microbiology, 7th ed, Murray P. editor, Washington DC: ASM Press; 1999;35: 1374-1382.
2. Montoya JG, Hesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425): 1965-1976.
3. Subauste CS, Remington JS. Immunity to Toxoplasma gondii. Curr Opin Immunol. 1993;5(4): 532-537.
4. Montoya JG, Remington JS. Toxoplasma gondii. In: Mandell GL, Beneth JE, Dohin R, editors. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000: 2858-2888.
5. Bretagne S, Costa JM, Fluery-Feith J, Poron F, Dubreuil-Lemaire ML, Vidaud M. Quantitative competitive PCR with broncho-alveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol. 1995;33(6): 1662-1664.
6. Danise A, Cinque P, Vergani S, et al. Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1997;24(6): 1100-1106.
7. Levy RM, Rosenbloom S, Perrett LV. Neurologic findings in AIDS; a review of 2000 cases. AJR AM J Roetgenol. 1986;147(5): 977-983.
8. Levy RM, Mills CM, Posin JP, Moore SO, Rosenblum ML, Bredesn DE. The efficacy and clinical impact of brain imaging in neurological symptomatic AIDS patients a prospective CT/MRI study. J Acquir Immune Defic Syndr. 1990;3(5): 461-471.
9. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986; 19(3): 224-238.
10. Foulon W. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol. 1999;180: 410-415.
11. Lones JL, Kruzson D. Toxoplasma gondii infection in US 1999-2000. Emerg Infect Dis. 2003;9: 11.
12. Nissapatorn V, Lee CKC, Cho SM, et al. Toxoplasmosis in HIV/AIDS patients in Malaysia. Southeast Asian J Trop Med Public Health. 2003; 34(2): 80-85.
13. Wanachiwanawin D, Sutthent T, Chokephaibultkit K, Mahakittikun V, Ongrotchnakun J, Monkong N. Toxoplasma gondii antibodies in HIV and non HIV infected Thai pregnant women. Asian Pac J Allergy Immunol. 2001;19: 291-293.
14. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med. 1997;43: 93-97.
15. Galva Ramirez ML, Valdez Alvarodo V, Vargas Gutierrez G, Jimenez Gonzalez O, Garcia Cosio C, Vielma Sandoval M. Prevalence of IgG and Igm anti-Toxoplasma antibodies in patients with HIV and AIDS. Rev Soc Bras Med Trop. 1997;30: 465-467.
16. Lindstrom I, Kaddu-Mulindwa DH, Kironde F, Lindh J. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patient from Uganda. Acta Trop. 2006;100(3): 218-222.
17. Eliaszewicz M, Lecomte I, De Sa M. Relation between decreasing series CD4 lymphocyte count and outcome of toxoplasmosis in AIDS patients: a basis for primary prophylaxis. Int Conf AIDS. 1990;6(242): 20-23.
18. Johnson LL, Sayles PC. Def icient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun. 2002;70(1): 185-219.